Flagship Pioneering announced that former FDA commissioner Dr. Stephen Hahn will lead its Preemptive Medicine & Health Security initiative.
A “bioinnovation platform company,” Flagship Pioneering has originated and fostered more than 100 scientific ventures totaling more than $90 billion in aggregate value, according to the company.
Get the full story at our sister site, Drug Discovery & Development.
FDA veteran Dr. Janet Woodcock has been tapped as interim FDA commissioner by the Biden administration, according to published reports.
An article by BioCentury also said that former FDA commissioner David Kessler, who had been mentioned as a possible replacement for current commissioner Stephen Hahn, will be a consultant to the agency but will not serve as its head. Another former FDA official, Joshua Sharfstein, remains in the running for the commissioner’s slot, according to BioCentury.
Get the full story on our sister site, Medical Design & Outsourcing.
Outgoing FDA commissioner Stephen Hahn says he needs some time to reflect on his future after leading the FDA for a little over a year.
It’s hard to blame him.
Hahn’s brief tenure at FA has been rocky, to say the least.
Get the full story on our sister site, Medical Design & Outsourcing.